Octavio Espinoza
Chief Financial Officer · 5 filings · Latest: May 27, 2026
LIGAND PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LGND | Octavio Espinoza | Chief Financial Officer | May 27, 2026 | Option Exercise | $57.58 | 1,736 | $100.0K | 27,679 | |
LGND | Octavio Espinoza | Chief Financial Officer | Mar 11, 2026 | Sale | $225.00 | 3,057 | $687.8K | 21,010 | |
LGND | Octavio Espinoza | Chief Financial Officer | Mar 11, 2026 | Option Exercise | $92.65 | 2,405 | $222.8K | 24,067 | |
LGND | OCTAVIO ESPINOZA | — | Mar 11, 2026 | Proposed Sale | $212.29 | 3,057 | $649.0K | — | |
LGND | Octavio Espinoza | Chief Financial Officer | Mar 4, 2026 | Sale | $205.83 | 13,423 | $2.8M | 21,662 | |
LGND | Octavio Espinoza | Chief Financial Officer | Mar 4, 2026 | Option Exercise | $63.49 | 2,073 | $131.6K | 35,085 | |
LGND | OCTAVIO ESPINOZA | — | Mar 4, 2026 | Proposed Sale | $204.24 | 13,423 | $2.7M | — | |
LGND | OCTAVIO ESPINOZA | — | Dec 12, 2025 | Proposed Sale | $188.31 | 1,804 | $339.7K | — | |
LGND | Espinoza Octavio | — | Mar 4, 2025 | Proposed Sale | $115.03 | 5,000 | $575.1K | — | |
LGND | Espinoza Octavio | — | Dec 23, 2024 | Proposed Sale | $116.37 | 2,104 | $244.9K | — | |
LGND | Espinoza Octavio | — | Sep 20, 2024 | Proposed Sale | $103.94 | 1,275 | $132.5K | — |